Quarterly report · Q3
4361.TEDINET S100PAIT
Period2021-12-01 → 2022-08-31
Filed2022-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.1bn | 2021-12-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥7.9bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.8bn | 2020-12-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥331m | 2021-12-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥347m | 2020-12-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥345m | 2021-12-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥386m | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥349m | 2020-12-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥343m | 2021-12-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥357m | 2020-12-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥266m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥281m | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥259m | 2020-12-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥266m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥259m | 2020-12-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥8.3bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥7.9bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥7.7bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥5.6bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.5bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2021-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥218.07 | 2021-12-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.01 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.99 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.08 | 2020-12-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.78 | 2021-06-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 29.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥308m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥29m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥29m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-08-31 | ¥331m |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥5.7bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥5.7bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥324m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥28m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥28m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-08-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-08-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-08-31 | ¥347m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 352
| Item | Context | Value | Unit |
|---|---|---|---|
| Selling general and administrative expenses | Prior1YTDDuration | 861057000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 875830000 | JPY |
| Operating income | Prior1YTDDuration | 346641000 | JPY |
| Operating income | CurrentYTDDuration | 331055000 | JPY |
| Interest income noi | Prior1YTDDuration | 539000 | JPY |
| Interest income noi | CurrentYTDDuration | 1648000 | JPY |
| Dividends income noi | Prior1YTDDuration | 1852000 | JPY |
| Dividends income noi | CurrentYTDDuration | 2629000 | JPY |
| Insurance income noi | Prior1YTDDuration | 1064000 | JPY |
| Insurance income noi | CurrentYTDDuration | － | JPY |
| Commission fee noi | Prior1YTDDuration | 2300000 | JPY |
| Commission fee noi | CurrentYTDDuration | － | JPY |
| Compensation income noi | Prior1YTDDuration | － | JPY |
| Compensation income noi | CurrentYTDDuration | 2384000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 4409000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 14536000 | JPY |
| Other noi | Prior1YTDDuration | 5383000 | JPY |
| Other noi | CurrentYTDDuration | 5860000 | JPY |
| Non operating income | Prior1YTDDuration | 15549000 | JPY |
| Non operating income | CurrentYTDDuration | 27058000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 13057000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 13188000 | JPY |
| Provision of allowance for doubtful accounts noe | Prior1YTDDuration | 150000 | JPY |
| Provision of allowance for doubtful accounts noe | CurrentYTDDuration | － | JPY |
| Other noe | Prior1YTDDuration | 387000 | JPY |
| Other noe | CurrentYTDDuration | 88000 | JPY |
| Non operating expenses | Prior1YTDDuration | 13595000 | JPY |
| Non operating expenses | CurrentYTDDuration | 13276000 | JPY |
| Ordinary income | Prior1YTDDuration | 348596000 | JPY |
| Ordinary income | CurrentYTDDuration | 344837000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 1164000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | － | JPY |
| A state government subsidy income ei | Prior1YTDDuration | 10091000 | JPY |
| A state government subsidy income ei | CurrentYTDDuration | － | JPY |
| Extraordinary income | Prior1YTDDuration | 11255000 | JPY |
| Extraordinary income | CurrentYTDDuration | － | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 2352000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 1736000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 2352000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 1736000 | JPY |
| Income before income taxes | Prior1YTDDuration | 357498000 | JPY |
| Income before income taxes | CurrentYTDDuration | 343101000 | JPY |
| Income taxes current | Prior1YTDDuration | 87220000 | JPY |
| Income taxes current | CurrentYTDDuration | 72567000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 10791000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 5019000 | JPY |
| Income taxes | Prior1YTDDuration | 98011000 | JPY |
| Income taxes | CurrentYTDDuration | 77586000 | JPY |
| Profit loss | Prior1YTDDuration | 259487000 | JPY |
| Profit loss | CurrentYTDDuration | 265514000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |